Oxoid Salmonella 9-0 Recall - Remel/Thermo Fisher Scientific
Summary
ANSM issued safety notice R2608613 informing medical biology laboratories of a field safety corrective action by Remel/Thermo Fisher Scientific, involving the recall of 847 units of Oxoid Salmonella agglutinating sera (Salmonella 9-0). Affected users received a direct communication from Thermo Fisher Scientific with instructions. Laboratories should verify their inventory for affected lots and contact the manufacturer directly.
What changed
ANSM recorded field safety corrective action R2608613 involving Remel/Thermo Fisher Scientific and the recall of 847 units of Oxoid Salmonella agglutinating sera (Salmonella 9-0). The notice references a manufacturer letter dated 31/03/2026 providing further details on the affected lots. ANSM directed inquiries to the issuing company directly.
Medical biology laboratories that may hold affected units of Oxoid Salmonella 9-0 agglutinating sera should immediately review the manufacturer correspondence attached to this notice, verify their inventory for impacted lots, discontinue use of any recalled product, and contact Remel/Thermo Fisher Scientific to arrange return or replacement per the instructions provided.
What to do next
- Review the attached Thermo Fisher Scientific letter (dated 31/03/2026) for affected lot numbers
- Verify inventory for recalled Oxoid Salmonella 9-0 agglutinating sera units
- Contact Remel/Thermo Fisher Scientific directly to coordinate product return or replacement
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Rappel n° R2608613 destiné aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre du retrait de plusieurs lots effectué par la société Remel / Thermo Fisher Scientific.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608613.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Thermo Fisher Scientific (31/03/2026)
Named provisions
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.